The Implantable Collamer Lens with a central port: review of the literature

Mark Packer Mark Packer MD Consulting, Inc., Boulder, CO, USA Abstract: The purpose of this review is to summarize preclinical and clinical data from publications appearing in the peer-reviewed scientific literature relevant to the safety and effectiveness of the EVO Implantable Collamer Lens (ICL...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Packer M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	myopia astigmatism hyperopia phakic refractive lens Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/e21adccaa7b049ada9414433efeddad2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e21adccaa7b049ada9414433efeddad2
record_format	dspace
spelling	oai:doaj.org-article:e21adccaa7b049ada9414433efeddad22021-12-02T07:02:49ZThe Implantable Collamer Lens with a central port: review of the literature1177-5483https://doaj.org/article/e21adccaa7b049ada9414433efeddad22018-11-01T00:00:00Zhttps://www.dovepress.com/the-implantable-collamer-lens-with-a-central-port-review-of-the-litera-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Mark Packer Mark Packer MD Consulting, Inc., Boulder, CO, USA Abstract: The purpose of this review is to summarize preclinical and clinical data from publications appearing in the peer-reviewed scientific literature relevant to the safety and effectiveness of the EVO Implantable Collamer Lens (ICL) posterior chamber phakic refractive lens with a central port (V4c Visian ICL with KS Aquaport, STAAR Surgical, Inc.). A literature search was conducted using PubMed.gov to identify all articles relating to the EVO ICL. Articles were examined for their relevance, and the references cited in each article were also searched for additional relevant publications. On the basis of a total of 67 preclinical studies and clinical reports, including effectiveness data on 1,905 eyes with average weighted follow-up of 12.5 months and safety data on 4,196 eyes with weighted average follow up of 14.0 months, the EVO ICL is safe and effective for the correction of a broad range of refractive errors. High levels of postoperative uncorrected visual acuity, refractive predictability, and stability demonstrate the effectiveness of the EVO ICL. Safety data suggest reduced rates of anterior subcapsular cataract and pupillary block compared with earlier models. Improved safety and proven effectiveness make EVO an attractive option for surgeons and patients. Keywords: myopia, astigmatism, hyperopia, phakic refractive lensPacker MDove Medical Pressarticlemyopiaastigmatismhyperopiaphakic refractive lensOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 12, Pp 2427-2438 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	myopia astigmatism hyperopia phakic refractive lens Ophthalmology RE1-994
spellingShingle	myopia astigmatism hyperopia phakic refractive lens Ophthalmology RE1-994 Packer M The Implantable Collamer Lens with a central port: review of the literature
description	Mark Packer Mark Packer MD Consulting, Inc., Boulder, CO, USA Abstract: The purpose of this review is to summarize preclinical and clinical data from publications appearing in the peer-reviewed scientific literature relevant to the safety and effectiveness of the EVO Implantable Collamer Lens (ICL) posterior chamber phakic refractive lens with a central port (V4c Visian ICL with KS Aquaport, STAAR Surgical, Inc.). A literature search was conducted using PubMed.gov to identify all articles relating to the EVO ICL. Articles were examined for their relevance, and the references cited in each article were also searched for additional relevant publications. On the basis of a total of 67 preclinical studies and clinical reports, including effectiveness data on 1,905 eyes with average weighted follow-up of 12.5 months and safety data on 4,196 eyes with weighted average follow up of 14.0 months, the EVO ICL is safe and effective for the correction of a broad range of refractive errors. High levels of postoperative uncorrected visual acuity, refractive predictability, and stability demonstrate the effectiveness of the EVO ICL. Safety data suggest reduced rates of anterior subcapsular cataract and pupillary block compared with earlier models. Improved safety and proven effectiveness make EVO an attractive option for surgeons and patients. Keywords: myopia, astigmatism, hyperopia, phakic refractive lens
format	article
author	Packer M
author_facet	Packer M
author_sort	Packer M
title	The Implantable Collamer Lens with a central port: review of the literature
title_short	The Implantable Collamer Lens with a central port: review of the literature
title_full	The Implantable Collamer Lens with a central port: review of the literature
title_fullStr	The Implantable Collamer Lens with a central port: review of the literature
title_full_unstemmed	The Implantable Collamer Lens with a central port: review of the literature
title_sort	implantable collamer lens with a central port: review of the literature
publisher	Dove Medical Press
publishDate	2018
url	https://doaj.org/article/e21adccaa7b049ada9414433efeddad2
work_keys_str_mv	AT packerm theimplantablecollamerlenswithacentralportreviewoftheliterature AT packerm implantablecollamerlenswithacentralportreviewoftheliterature
_version_	1718399666975932416

The Implantable Collamer Lens with a central port: review of the literature

Ejemplares similares